Our broader analyses implicated NEAT1 in influencing multiple metabolic traits (e.g. serum triglycerides, diagnosis of T2DM and coronary artery disease), that are of potential relevance to patients with NAFLD. Here, NEAT1 is linked to type 2 diabetes mellitus.